Replies to post #103124 on Regen BioPharma Inc (RGBP)

[29YEARINVESTOR]

Thanks! I Agree!
Ongoing Agreement With Eli Lilly Leads to Discovery of Several New Small Molecule Drugs

https://www.hvst.com/posts/ongoing-agreement-with-eli-lilly-leads-to-discovery-of-several-new-small-molecule-drugs-wm4T1ZDp

ELI LILLY HAS BEEN WAITING ON THE RGBP HUMAN PATENT.
WHICH RGBP JUST GOT APPROVED: 9/23/2021
Rgbp was ahead of its time with there patented technology until COVID brought this MRNA technology to the forefront! Now RGBP has many patents including the New NR2F6 Patent for humans in place. That We have all been waiting for.

Eli Lilly and RGBP have a good history and Eli Lilly was waiting on the human patent RGBP JUST GOT APPROVED:

Eli Lilly (LLY) & RGBP Partner in Small Molecules Immuno-Oncology - Autoimmunization NR2F6 Program. They Currently Await New Patents, Etc. News of Approval.
The Intended Result is Oral Drugs-Therapies-Treatment for Cancers & Auto Immune Diseases.
Specializing in Cutting Edge Technology.

https://www.otcmarkets.com/filing/html?id=15246005&guid=0UBwkePH2yzmJth

Check out the new patents that we have all been waiting for along with what Eli Lilly was waiting for from previous studies together!
The sky is the limit IMO!

$RGBP $RGBPP connection to $LLY (Eli Lilly one of the TOP pharmaceutical co in the world)
Jean-Pierre Millon was executive 23 years @ LLY and would not have been associated with Regen unless he knew the significance of NR2F6 imo
Connected to $CVS n GPP a $2.2 TRILLION hedge fund! pic.twitter.com/o0C7Hz8k3R

— ⚡️420⚡️ (@WZ_420) August 29, 2021

https://www.biospace.com/article/releases/regen-biopharma-inc-announces-former-eli-lilly-executive-and-current-cvs-board-member-will-lead-newly-formed-business-advisory-board-bab-/

https://www.prnewswire.com/news-releases/regen-biopharma-inc-enters-into-open-innovation-drug-discovery-program-agreement-with-eli-lilly-and-company-585014641.html

[Natureboy1]

His last name is $MILLION$. Ha ha ha! Love it! Bring us the millions DR. $Million!